Inogen, Inc - stock earnings
INGN Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 7, 2024 AfterMarket | - / -0.7732000000 | - | - / 75.1 million | - |
INGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -26.6 million USD | 75.9 million USD |
| 2023Q3 | -45.7 million USD | 84.0 million USD |
| 2023Q2 | -9.8 million USD | 83.6 million USD |
| 2023Q1 | -20.3 million USD | 72.2 million USD |
| 2022Q4 | -56.6 million USD | 88.1 million USD |
| 2022Q3 | -9.5 million USD | 105.4 million USD |
| 2022Q2 | -3.4 million USD | 103.4 million USD |
| 2022Q1 | -14.2 million USD | 80.4 million USD |
| 2021Q4 | -22.9 million USD | 76.4 million USD |
| 2021Q3 | 12.2 million USD | 93.1 million USD |
| 2021Q2 | 5.1 million USD | 101.6 million USD |
| 2021Q1 | -732000 USD | 86.9 million USD |
| 2020Q4 | -5.1 million USD | 74.0 million USD |
| 2020Q3 | -1.7 million USD | 74.3 million USD |
| 2020Q2 | 2.6 million USD | 71.7 million USD |
| 2020Q1 | -1.6 million USD | 88.5 million USD |
| 2019Q4 | -1.4 million USD | 78.9 million USD |
| 2019Q3 | 6.9 million USD | 91.8 million USD |
| 2019Q2 | 10.2 million USD | 101.1 million USD |
| 2019Q1 | 5.3 million USD | 90.2 million USD |
| 2018Q4 | 10.0 million USD | 86.5 million USD |
| 2018Q3 | 16.4 million USD | 95.3 million USD |
| 2018Q2 | 14.6 million USD | 97.2 million USD |
| 2018Q1 | 10.8 million USD | 79.1 million USD |
| 2017Q4 | -606000 USD | 63.8 million USD |
| 2017Q3 | 7.3 million USD | 69.0 million USD |
| 2017Q2 | 8.3 million USD | 64.1 million USD |
| 2017Q1 | 5.9 million USD | 52.5 million USD |
| 2016Q4 | 5.3 million USD | 50.9 million USD |
| 2016Q3 | 3.5 million USD | 54.4 million USD |
| 2016Q2 | 5.1 million USD | 54.6 million USD |
| 2016Q1 | 2.4 million USD | 43.0 million USD |
| 2015Q4 | 3.9 million USD | 40.4 million USD |
| 2015Q3 | 2.7 million USD | 40.8 million USD |
| 2015Q2 | 3.5 million USD | 44.0 million USD |
| 2015Q1 | 1.5 million USD | 29.1 million USD |
| 2014Q4 | 1.5 million USD | 29.1 million USD |
| 2014Q3 | 2.1 million USD | 29.4 million USD |
| 2014Q2 | 2.3 million USD | 30.4 million USD |
| 2014Q1 | 22.0 million USD | 19.8 million USD |
| 2013Q4 | 22.0 million USD | 19.8 million USD |
| 2013Q3 | 774000 USD | 19.8 million USD |
| 2013Q2 | 2.0 million USD | 20.2 million USD |
| 2013Q1 | 730000 USD | 15.7 million USD |
| 2012Q4 | 108000 USD | 13.8 million USD |
INGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -102.4 million USD | 315.7 million USD |
| 2022 | -83.8 million USD | 377.2 million USD |
| 2021 | -6.3 million USD | 358.0 million USD |
| 2020 | -5.8 million USD | 308.5 million USD |
| 2019 | 21.0 million USD | 361.9 million USD |
| 2018 | 51.8 million USD | 358.1 million USD |
| 2017 | 21.0 million USD | 249.4 million USD |
| 2016 | 20.5 million USD | 202.8 million USD |
| 2015 | 11.6 million USD | 159.0 million USD |
| 2014 | 6.8 million USD | 112.5 million USD |
| 2013 | 25.4 million USD | 75.4 million USD |
| 2012 | 564000 USD | 48.6 million USD |
| 2011 | -2.0 million USD | 30.6 million USD |
INGN
Price: $7.19
52 week price:
Earnings Per Share: -4.42 USD
P/E Ratio: -1.33
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 86424
Ebitda: 11.8 millionMarket Capitalization: 172.6 million